CN109620951A - One kind helping pregnant composition and preparation method thereof - Google Patents
One kind helping pregnant composition and preparation method thereof Download PDFInfo
- Publication number
- CN109620951A CN109620951A CN201811621491.6A CN201811621491A CN109620951A CN 109620951 A CN109620951 A CN 109620951A CN 201811621491 A CN201811621491 A CN 201811621491A CN 109620951 A CN109620951 A CN 109620951A
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- pregnant
- vitamin
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 34
- 239000000843 powder Substances 0.000 claims abstract description 23
- 241000287828 Gallus gallus Species 0.000 claims abstract description 16
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 8
- 230000036541 health Effects 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 7
- 235000008397 ginger Nutrition 0.000 claims abstract description 7
- 235000013376 functional food Nutrition 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000011669 selenium Substances 0.000 claims description 15
- 239000011701 zinc Substances 0.000 claims description 15
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 14
- 229910052725 zinc Inorganic materials 0.000 claims description 14
- 102000008186 Collagen Human genes 0.000 claims description 11
- 108010035532 Collagen Proteins 0.000 claims description 11
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 11
- 229920001436 collagen Polymers 0.000 claims description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- 229910052711 selenium Inorganic materials 0.000 claims description 11
- 229920001202 Inulin Polymers 0.000 claims description 10
- 239000003292 glue Substances 0.000 claims description 10
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 10
- 229940029339 inulin Drugs 0.000 claims description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- 229930003231 vitamin Natural products 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 8
- 239000011782 vitamin Substances 0.000 claims description 8
- 229940088594 vitamin Drugs 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 7
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 7
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 7
- 235000019441 ethanol Nutrition 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 235000013311 vegetables Nutrition 0.000 claims description 7
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 244000273928 Zingiber officinale Species 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 6
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 5
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 240000001008 Dimocarpus longan Species 0.000 claims description 3
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 3
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 3
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 3
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 3
- 235000000235 Euphoria longan Nutrition 0.000 claims description 3
- 240000000759 Lepidium meyenii Species 0.000 claims description 3
- 235000000421 Lepidium meyenii Nutrition 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- 240000002853 Nelumbo nucifera Species 0.000 claims description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 3
- 244000046146 Pueraria lobata Species 0.000 claims description 3
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical group Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 3
- 235000012902 lepidium meyenii Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- -1 pollen pini Substances 0.000 claims description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- 239000011691 vitamin B1 Substances 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 239000011726 vitamin B6 Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 244000192528 Chrysanthemum parthenium Species 0.000 claims 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims 1
- 244000126002 Ziziphus vulgaris Species 0.000 claims 1
- 229910052750 molybdenum Inorganic materials 0.000 claims 1
- 239000011733 molybdenum Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 230000035558 fertility Effects 0.000 abstract description 8
- 210000000287 oocyte Anatomy 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000002611 ovarian Effects 0.000 abstract description 4
- 210000000056 organ Anatomy 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 241000234314 Zingiber Species 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 21
- 238000012360 testing method Methods 0.000 description 15
- 235000013601 eggs Nutrition 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 13
- 210000002966 serum Anatomy 0.000 description 13
- 241000700159 Rattus Species 0.000 description 11
- 230000036737 immune function Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 210000000822 natural killer cell Anatomy 0.000 description 8
- 238000011049 filling Methods 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000000509 infertility Diseases 0.000 description 6
- 230000036512 infertility Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 231100000535 infertility Toxicity 0.000 description 5
- 208000021267 infertility disease Diseases 0.000 description 5
- 210000002540 macrophage Anatomy 0.000 description 5
- 230000000242 pagocytic effect Effects 0.000 description 5
- 230000035935 pregnancy Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 241000207925 Leonurus Species 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007928 intraperitoneal injection Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical group O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 3
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 238000005534 hematocrit Methods 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 239000000976 ink Substances 0.000 description 3
- 206010036601 premature menopause Diseases 0.000 description 3
- 208000017942 premature ovarian failure 1 Diseases 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 206010021928 Infertility female Diseases 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 206010040925 Skin striae Diseases 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 240000008866 Ziziphus nummularia Species 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 150000002751 molybdenum Chemical class 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 210000004988 splenocyte Anatomy 0.000 description 2
- 238000011121 vaginal smear Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 235000019083 Osmanthus fragrans Nutrition 0.000 description 1
- 244000242564 Osmanthus fragrans Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 235000011609 Pinus massoniana Nutrition 0.000 description 1
- 241000018650 Pinus massoniana Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000081923 Rumex patientia Species 0.000 description 1
- 235000008330 Rumex patientia Nutrition 0.000 description 1
- 241000951473 Schizonepeta Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 241001533115 Thesium chinense Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 229940118199 levulan Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Insects & Arthropods (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Marine Sciences & Fisheries (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Abstract
The invention discloses one kind to help pregnant composition, raw material including following parts by weight: 2-6 parts of semen sojae atricolor, 5-13 parts of black-bone chicken albumen powder, 1-7 parts of pollen pini, 1-6 parts of L-carnitine, 4-9 parts and Radix Angelicae Sinensis 2-8 parts of ginger, it additionally provides the above-mentioned preparation method for helping pregnant composition and its is preparing the application in health care product and/or functional food, it is provided by the invention to help pregnant composition, it has no toxic side effect, raw material in formula interacts, prescription is scientific and reasonable, adjust tonifying five zang organs, play integrally-regulated advantage, female endocrinic disorders can effectively be adjusted, improve ovarian function, improve oocyte quality, improve female fertility.
Description
Technical field
The invention belongs to health care product and/or functional food fields, and in particular to one kind helps pregnant composition and preparation method thereof.
Background technique
Since infertility is known as female sterility caused by female factors, female sterility be a kind of disease incidence compared with
High and more refractory illness more.Research data shows at present both at home and abroad: disease incidence of the infertility in child-bearing period Mr. and Mrs is about
For 15%-20%, root according to the statistics of the World Health Organization: the whole world about 600-8000 ten thousand suffers from different degrees of infertility to Mr. and Mrs
Disease, wherein the infertility as caused by female factors accounts for about the 50% of all infertile couples.Female fertility is in the increase at age
Downward trend, the probability being pregnant in 1 year can reach 90% at 20 years old, and be only 36.4% at 40 years old or so.Chinese population base
Number is big, and the opening of two child's policies in recent years, has the advanced age Mr. and Mrs of fertility demand more and more, the disease incidence of sterility is in recent years
Also in rising trend.The cause of disease of atocia is varied, most directly shows as endocrine disturbance, premature ovarian failure, ovum
Cell quality decline.
CN103316238A discloses a kind of Chinese medicine for treating fertility, is made of the medicinal material of following parts by weight: king is not
Stay 12 parts of row, 12 parts of cortex cinnamomi, 10 parts of dark plum, 14 parts of Rhizoma Chuanxiong, 10 parts of fennel seeds, 6 parts of sweet osmanthus, 8 parts of rose, 10 parts of clearvers,
12 parts of Herba Cyperi Glomerati, 13 parts of Thesium chinese, 14 parts of amur foxtail, 12 parts of motherwort, 12 parts of root of Rumex patientia L., 12 parts of Radix Paeoniae Alba, clinical test proves,
The present invention can safely and effectively treat fertility.CN106860717A disclose it is a kind of treat infertile drug, according to
The raw material of parts by weight includes: 3-8 parts of fennel seeds, 5-10 parts of corydalis tuber, 3-8 parts of myrrh, 5-10 parts of Radix Angelicae Sinensis, 5-10 parts of Rhizoma Chuanxiong, cortex cinnamomi
8-15 parts, 1-3 parts of excrementum pteropi, 3-8 parts of motherwort, 3-8 parts of rhizoma cyperi, 8-15 parts of semen ziziphi spinosae, 1-3 parts of fushen, 1-3 parts of Radix Codonopsis, mountain
5-10 parts of the fruit of medicinal cornel, 3-8 parts of radix scutellariae, 1-5 parts of schizonepeta, 8-15 parts of Fructus Forsythiae, the invention is to caused by uncomfortable equal inferior healths reason
It is infertile have it is effective.
In the prior art, the composition for improving and treating female acyesis, which focuses mostly on, to be changed to palace cold, inferior health the problems such as
It is kind, and it is poor to the specific aim of infertility caused by oocyte quality problem, and it is infertile to oocyte quality treatment is improved at present
Research it is less, CN107927790A discloses a kind of composition, including trehalose and L-carnitine, although the invention can mention
High oocyte quality, but the invention has a single function, and therapeutic effect is not significant, can not effectively improve the fertility energy of women
Power.
Summary of the invention
The present invention provides one kind to help pregnant composition, and the composition is safe and reliable, has no toxic side effect, and can effectively adjust women
Endocrine disturbance improves ovarian function, improves oocyte quality, improves female fertility.
To achieve the goals above, the invention adopts the following technical scheme:
One kind helping pregnant composition, the raw material including following parts by weight: 2-6 parts of semen sojae atricolor, 5-13 parts of black-bone chicken albumen powder, and pollen pini
1-7 parts, 1-6 parts of L-carnitine, 4-9 parts of ginger and 2-8 parts of Radix Angelicae Sinensis.
Preferably, described to help pregnant composition, the raw material including following parts by weight: 3-6 parts of semen sojae atricolor, black-bone chicken albumen powder 6-13
Part, 2-7 parts of pollen pini, 2-6 parts of L-carnitine, 5-9 parts of ginger and 4-8 parts of Radix Angelicae Sinensis.
In some preferred embodiments, described to help pregnant composition, further include the raw material of following parts by weight: zinc-rich is rich
5-10 parts of selenium dried whole-egg, 1-5 parts of fructus lycii, 2-7 parts of Chinese yam, 2-6 parts of lotus seeds, 3-8 parts of longan, 1-5 parts of cortex cinnamomi and 5-15 parts of jujube;
Preferably, the mass ratio of the cortex cinnamomi and Zinc-enriched selenium-enriched dried whole-egg is 1:3.
In some preferred embodiments, described to help pregnant composition, it further include the raw material of following parts by weight: fruit vegetable powder
8-15 parts, 1-8 parts of motherwort, 1-5 parts of trehalose, 1-6 parts of pueraria lobata, 2-8 parts of folium artemisiae argyi and 0.001-0.005 parts of vitamin;It is preferred that
The mass ratio of ground, the trehalose and folium artemisiae argyi is 1:2.
In some preferred embodiments, described to help pregnant composition, it further include the raw material of following parts by weight: honey 5-
10 parts, 3-8 parts of inulin, 2-7 parts of Isin glue collagen peptide, 1-5 parts of maca and 0.0001-0.0005 parts of microelement;Preferably, institute
The mass ratio for stating inulin and Isin glue collagen peptide is 1.5:1.
Preferably, the vitamin is vitamin C, vitamin E, folic acid, vitamin B1, vitamin B2, vitamin B6、
Vitamin B12, one of niacin and pantothenic acid or a variety of.
Preferably, the microelement is one of molysite, mantoquita and molybdenum salt or a variety of.
The present invention also provides a kind of preparation methods for helping pregnant composition, comprising the following steps:
(1) black-bone chicken albumen powder, pollen pini, Zinc-enriched selenium-enriched dried whole-egg, fruit vegetable powder, honey, inulin, Isin glue collagen will be removed
All raw materials except peptide, vitamin and microelement are freeze-dried, are crushed into powder after the dosage mixing of composition of raw materials,
Obtain mixture A;
(2) obtained mixture A is extracted with ethanol solution, is filtered after merging filtrate, is concentrated under reduced pressure to give medicinal extract B,
The mass ratio of the mixture A and ethyl alcohol are 1:(4-7);
(3) obtained medicinal extract B is obtained into mixture C after drying, crushing, sieving;
(4) mixture C that step (3) obtains is sufficiently mixed with remaining raw material is formulated, obtains described helping pregnant composition.
The condition of extraction described in step (2) are as follows: extracted 3 times at 60-70 DEG C, each extraction time is 3 hours, institute
The ethanol solution stated is the ethanol water that volume fraction is 60-80%.
Sieving described in step (3) was 80 meshes.
It is of the present invention to help pregnant composition that be prepared as pulvis, tablet, pill, it can also be used as the addition of bottom side at it
In his product.
The present invention also provides described, and pregnant composition to be helped to prepare the application in health care product and/or functional food.
The invention has the benefit that
(1) provided by the invention to help pregnant composition, it has no toxic side effect, the raw material in formula interacts, and prescription science is closed
Reason adjusts tonifying five zang organs, plays integrally-regulated advantage, has and adjusts endocrine disturbance, improves ovarian function, improves ooplasm
Amount, improves the effect of female fertility.
(2) provided by the invention to help pregnant composition that improve woman preparing for pregnancy constitution, have nourishing yin and supplementing blood, raising immune
The effect of power, while the effect of interior free yl can be removed, improve skin elasticity, prevents the shape of pregnancy period cyasma and striae of pregnancy
At.
Specific embodiment
In order to make the object, technical scheme and advantages of the embodiment of the invention clearer, below to technical solution of the present invention
It is further described.
When embodiment provides numberical range, it should be appreciated that except non-present invention is otherwise noted, two ends of each numberical range
Any one numerical value can be selected between point and two endpoints.Unless otherwise defined, all technologies used herein and section
Technics has and the normally understood identical meaning of general technical staff of the technical field of the invention.
Unless otherwise specified, raw material of the present invention is ordinary commercial products.
Basic embodiment
One kind helping pregnant composition, the raw material including following parts by weight: 2-6 parts of semen sojae atricolor, 5-13 parts of black-bone chicken albumen powder, and pollen pini
1-7 parts, 1-6 parts of L-carnitine, 4-9 parts of ginger and 2-8 parts of Radix Angelicae Sinensis.
Preferably, described to help pregnant composition, the raw material including following parts by weight: 3-6 parts of semen sojae atricolor, black-bone chicken albumen powder 6-13
Part, 2-7 parts of pollen pini, 2-6 parts of L-carnitine, 5-9 parts of ginger and 4-8 parts of Radix Angelicae Sinensis.
In some preferred embodiments, described to help pregnant composition, further include the raw material of following parts by weight: zinc-rich is rich
5-10 parts of selenium dried whole-egg, 1-5 parts of fructus lycii, 2-7 parts of Chinese yam, 2-6 parts of lotus seeds, 3-8 parts of longan, 1-5 parts of cortex cinnamomi and 5-15 parts of jujube;
Preferably, the mass ratio of the cortex cinnamomi and Zinc-enriched selenium-enriched dried whole-egg is 1:3.
In some preferred embodiments, described to help pregnant composition, it further include the raw material of following parts by weight: fruit vegetable powder
8-15 parts, 1-8 parts of motherwort, 1-5 parts of trehalose, 1-6 parts of pueraria lobata, 2-8 parts of folium artemisiae argyi and 0.001-0.005 parts of vitamin;It is preferred that
The mass ratio of ground, the trehalose and folium artemisiae argyi is 1:2.
In some preferred embodiments, described to help pregnant composition, it further include the raw material of following parts by weight: honey 5-
10 parts, 3-8 parts of inulin, 2-7 parts of Isin glue collagen peptide, 1-5 parts of maca and 0.0001-0.0005 parts of microelement;Preferably, institute
The mass ratio for stating inulin and Isin glue collagen peptide is 1.5:1.
Preferably, the vitamin is vitamin C, vitamin E, folic acid, vitamin B1, vitamin B2, vitamin B6、
Vitamin B12, one of niacin and pantothenic acid or a variety of.
Preferably, the microelement is one of molysite, mantoquita and molybdenum salt or a variety of.
It is of the present invention to help pregnant composition that be prepared as pulvis, tablet, pill, it can also be used as the addition of bottom side at it
In his product.
The present invention also provides described, and pregnant composition to be helped to prepare the application in health care product and/or functional food.
Table 1-4 is the specific raw material components table of the present embodiment, wherein the "-" in table indicates that this content is not present.
Protein content is 85% in the black-bone chicken albumen powder that the present embodiment uses;The preparation method of Zinc-enriched selenium-enriched dried whole-egg
Are as follows: by the egg liquid and eggshell of Se-enriched egg and zinc-rich egg, moisture content is made according to conventional technical means in the art and is lower than
4.0% dried whole-egg, wherein the Se content of Se-enriched egg is greater than 0.2mg/kg, and the Zn content of zinc-rich egg is greater than 0.822mg/
The mass ratio of kg, zinc-rich egg and Se-enriched egg is 2:1;Pollen pini is commercially available common broken masson pine pollen;Isin glue collagen peptide
The content of middle protein is 97.5%;Fruit vegetable powder is grape, apple, lemon, pimento, tomato and carrot according to this field
The pulvis of conventional technical means preparation, the grape, apple, lemon, pimento, tomato and the mass ratio of carrot are 0.5:1:
0.2:1:1:2;The levulan content of inulin is 90%;Vitamin is vitamin E;Microelement is ferrous gluconate.
Raw material components (parts by weight) table of 1 embodiment 1-5 of table
Raw material components (parts by weight) table of 2 embodiment 6-10 of table
Raw material components (parts by weight) table of 3 embodiment 11-15 of table
Raw material components (parts by weight) table of 4 embodiment 16-20 of table
The preparation method for helping pregnant composition of above-described embodiment 1-20, comprising the following steps:
(1)) black-bone chicken albumen powder, pollen pini, Zinc-enriched selenium-enriched dried whole-egg, fruit vegetable powder, honey, inulin, Isin glue collagen will be removed
All raw materials except peptide, vitamin and microelement are freeze-dried, are crushed into powder after the dosage mixing of composition of raw materials,
Obtain mixture A;
(2) ethanol water that obtained mixture A volume fraction is 66% is extracted into extraction 3 times at 65 DEG C, often
It secondary 3 hours, filtered after merging filtrate, be concentrated under reduced pressure to give medicinal extract B, the mass ratio of the mixture A and ethyl alcohol is 1:5;
(3) obtained medicinal extract B is obtained into mixture C after drying, crushing, 80 meshes excessively;
(4) mixture C that step (3) obtains is sufficiently mixed with remaining raw material is formulated, crushes, crosses 80 meshes, obtain
It is described to help pregnant composition.
Comparative example 1
For basic components with embodiment 4, the difference with embodiment 4 is that black-bone chicken albumen powder is free of in formula;Preparation method
With embodiment 4.
Comparative example 2
For basic components with embodiment 4, the difference with embodiment 4 is that pollen pini is free of in formula;Preparation method is the same as real
Apply example 4.
Comparative example 3
For basic components with embodiment 8, the difference with embodiment 8 is that Zinc-enriched selenium-enriched dried whole-egg is free of in formula;Preparation
Method is the same as embodiment 8.
Comparative example 4
For basic components with embodiment 8, the difference with embodiment 8 is that cortex cinnamomi is free of in formula;Preparation method is the same as implementation
Example 8.
Comparative example 5
For basic components with embodiment 15, the difference with embodiment 15 is that trehalose is free of in formula;Preparation method is same
Embodiment 15.
Comparative example 6
For basic components with embodiment 15, the difference with embodiment 15 is that folium artemisiae argyi is free of in formula;Preparation method is the same as real
Apply example 15.
Comparative example 7
For basic components with embodiment 19, the difference with embodiment 19 is that Isin glue collagen peptide is free of in formula;Preparation
Method is the same as embodiment 19.
Influence of the experimental example 1 to egg cell
Experimental animal: 8 weeks female CD-1 mouse after birth
Mouse is randomly divided into 8 groups, every group 10, respectively control group, embodiment 1-5 group and comparative example 1-2 group.Implement
Example 1-5 group gives the composition of 1-5 of the embodiment of the present invention respectively, and comparative example 1-2 group gives the comparative example 1-2 composition of preparation,
According to the dosage of 20mg/kg, daily stomach-filling 1 time, control group gives the distilled water of equivalent and uses rush after successive administration 30 days
Super drug row object promotees super row, collects egg cell after mouse is euthanized, and assesses the quality and quantity of egg cell, and using in vitro fertilization
Its ability for forming blastaea of experimental evaluation.
Experimental result:
Influence of 5 present invention of table to egg cell
Group | Egg cell degradation ratio % | Blastocyst rate % |
Control group | 32.6 | 56.8 |
Example 1 group | 17.2* | 91.2* |
2 groups of embodiment | 17.4* | 90.5* |
3 groups of embodiment | 16.8* | 92.3* |
4 groups of embodiment | 14.8** | 96.8** |
5 groups of embodiment | 15.2** | 94.2** |
1 group of comparative example | 20.7 | 75.6 |
2 groups of comparative example | 19.9 | 80.2 |
Note: compared with the control group, * P < 0.05 has significant difference;* P < 0.01 has extremely significant sex differernce.
As shown in Table 5, the embodiment of the present invention 1-5 can improve the quality of egg cell, find simultaneously, when black in composition
When the mass ratio of egg white powder and pollen pini is 2:1, the quality of egg cell can be significantly improved.
Influence of the embodiment 2 to premature ovarian failure
Experimental animal: SD rat, weight 200-280g, female.
Modeling;It carries out continuous vaginal smear within 7 days before modeling, to observe the oestrous cycle of rat, selects the oestrous cycle normal
120 SD rats, rat is divided into control group (20) and model group (100) at random by weight.Control group intraperitoneal injection
Physiological saline 2 times, is spaced 11 days totally;Modeling group intraperitoneal injection of cyclophosphamide solution, totally 2 times, 90mg/kg (the 1st time), 50mg/
Kg (the 2nd time) is spaced 11 days;It is daily to carry out vaginal smear, the variation of observation oestrous cycle;It is disorderly when the model group female mice oestrous cycle
Disorderly, anoestrum extended, without oestrous cycle or estrus, indicated rat ovary early ageing modeling success, hormonal readiness changes conduct
Auxiliary reference index.
Experimental group: blank control group, model control group, embodiment 6-10 group and comparative example 3-4 group.
Test method: choosing 80 successful rats of modeling, is randomly divided into 8 groups by weight, and every group 10, embodiment 6-10
Group gives the composition of 6-10 of the embodiment of the present invention respectively, and comparative example 3-4 group gives the comparative example 3-4 composition of preparation, and every group
The dosage of rat is 0.5g/kg, and model control group and blank control group give isometric physiological saline, daily stomach-filling one
It is secondary, it successive administration 30 days, in last dose next day, detects each rats in test groups serum follicular stimulating hormone (FSH) and corpus luteum generates
The content of plain (LH).
Test result:
Table 6 detects the content of each group test rat blood serum FSH and LH
Group | LH(mIU/ml) | FSH(mIU/ml) |
Blank control group | 2.87±0.34 | 3.10±0.55 |
Model control group | 3.15±0.50# | 3.40±0.79# |
6 groups of embodiment | 2.65±0.23* | 2.73±0.47* |
7 groups of embodiment | 2.74±0.38* | 2.83±0.80* |
8 groups of embodiment | 2.15±0.26** | 2.45±0.62** |
9 groups of embodiment | 2.69±0.43* | 2.75±0.67* |
10 groups of embodiment | 2.29±0.32** | 2.56±0.58** |
3 groups of comparative example | 2.95±0.36 | 3.16±0.71 |
4 groups of comparative example | 2.90±0.34 | 3.20±0.58* |
Note: compared with blank control group, #P < 0.05 has significant difference;Compared with model control group, * P <
0.05, there is significant difference;* P < 0.01 has extremely significant sex differernce.
As shown in Table 6, compared with blank control group, model control group rat blood serum LH and FSH have significant difference, table
Bright model control group modeling success.Simultaneously it can be found that rat blood serum LH and FSH, table can be effectively reduced in the present invention from table 6
The bright present invention can be effectively improved and treat premature ovarian failure, restore ovarian function.When the matter of dried whole-egg Zinc-enriched selenium-enriched in composition
When amount is than being 3:1, effect is preferable.
Total antioxidation acts in 3 body of experimental example
Experimental animal: Kunming mouse, female mice, weight 18-22g.
Experimental group: control group, embodiment 11-20 group and comparative example 5-8 group.
Experimental method: mouse is randomly divided into 15 groups by weight, every group 10, embodiment 11-20 group gives this hair respectively
The composition of bright embodiment 11-20, comparative example 5-8 group give the comparative example 5-8 composition of preparation, and the dosage of every group of mouse is
0.1g/kg, control group give isometric physiological saline, and daily stomach-filling is primary, and after continuous gavage 30 days, every group of mouse pulls out eyeball
Take blood and the execution that dislocates, 3500r/min separates serum after being centrifuged 15 minutes, is placed in that -20 DEG C of preservation are alternative, total in measurement serum
Oxidation resistance (T-AOC).
Experimental result:
7 total antioxidation of table acts on (T-AOC) experimental data
Note: compared with the control group, * P < 0.05 has significant difference;* P < 0.01 has extremely significant sex differernce.
The T-AOC that can be seen that the mouse of control group from the experimental result of table 7 is 13.5U/ml, and the feeding present invention
The T-AOC of the mouse for helping pregnant composition provided is 21.2-29.9U/ml, therefore, provided by the invention that pregnant composition is helped to have
Oxidation resistant effect, the effect of can removing interior free yl, improve skin elasticity, prevent the shape of pregnancy period cyasma and striae of pregnancy
At.
4 strengthen immunity of experimental example
Detect foundation: Ministry of Public Health's " health food is examined and assessment technique specification " (version in 2003).
Experimental animal: Kunming mouse, female, weight 18-22g.
This composition human body recommended amounts are everyone daily 50ml (0.83ml/kg), and mouse experiment dosage is arranged low, just
Often, high 3 dosage levels, i.e., daily 4.15,8.30 and 24.90ml/kg (are respectively equivalent to 5,10, the 30 of human body recommended amounts
Times), while negative control group is set, experiment mice is randomly divided into 2 batches, 4 groups of every batch of, every group 10 according to weight.
Respectively weigh prepared by 5.25ml, 10.50ml and 31.25ml above-described embodiment 19 and comparative example 7 helps pregnant composition, point
Not plus pure water is to 50ml, is made into 0.11ml/ml, 0.21ml/ml and 0.63ml/ml strength solution respectively, stomach-filling volume is
0.2ml/10g weight, daily stomach-filling 1 time, negative control group give isometric pure water, continuous 30d.
4.1 cellular immune function
1, the mouse spleen lymphocyte transformation experiment (mtt assay) of ConA induction
It is sterile to take spleen, cell suspension is made.It is divided to two holes to be added in 24 well culture plates every a splenocyte suspension, every hole
1mL, a hole add 75 μ L ConA liquid (being equivalent to 7.5 μ g/mL), and 5%CO is set as control in another hole2, 37 DEG C of CO2It is trained in incubator
Support 72h.Culture terminates preceding 4h, and every hole gently sucks supernatant 0.7mL, and RPMI1640 of the 0.7mL without calf serum is added and trains
Nutrient solution, while 50 hole μ L/ MTT (5mg/mL) is added, continue to cultivate 4h.After culture, 1mL acid isopropyl alcohol is added in every hole,
Ultrasonic vibration (2 seconds), is completely dissolved purple crystal.Then it is dispensed into 96 well culture plates, each hole dispenses 3 holes as parallel
Sample measures OD value with enzyme-linked immunosorbent assay instrument with 570nm wavelength.ConA is not added with adding the OD value in the hole ConA to subtract
The OD value in hole represents the proliferative capacity of lymphocyte, and the light that the optical density difference of test sample group is significantly higher than control group is close
Difference is spent, can determine that this experimental result positive.
2, delayed allergy (DTH)
Stomach-filling the 26th day, it is used for sensitization to mouse peritoneal injection 2% sheep red blood cell (SRBC) (SRBC) 0.2mL, 4th after immune
It, auris dextra uniformly smears 20 μ L of 1%DNFB solution attack, and left ear compares, and in putting to death mouse for 24 hours after injection, takes left and right identical
The weighing of size auricle, the difference of weight is as swelling.The degree of DTH is indicated with swelling.The difference of test sample group is aobvious
The difference for being higher than control group is write, can determine that this experimental result positive.Thymus gland and the spleen weighing for taking mouse simultaneously, calculate dirty
Device/weight ratio.
4.2 humoral immune function
1, antibody-producting cell detection (Jerne improves slide method)
In the 26th day 2% (v/v) hematocrit SRBC to every mouse peritoneal injection 0.2mL of stomach-filling, 4-5 is immunized in SRBC
Mouse cervical dislocation after it is put to death, sterile to take spleen, is prepared into 5 × 10 with complete medium RPMI16406A cell/mL's
Splenocyte suspension.And agarose slide is made, put it into the CO of 37 DEG C, 5%21h is incubated in incubator, then every hole is added
500 μ L are continued to be incubated for 2h, be formed on every thin agar layer slide of counting with the diluted complement of complete medium (v/v, 1:10)
Hemolysis plaque number, with plaque number/106Splenocyte indicates antibody-producting cell number.
2, half hemolytic value (HC50) measurement
Hematocrit SRBC is made into the cell suspension of 2% (v/v) with physiological saline, every mouse intraperitoneal injection 0.2mL is exempted from
Epidemic disease.After 4d, extracts eyeball and takes blood in centrifuge tube, place about 1h, solidification blood and tube wall are removed, serum is precipitated sufficiently,
2000r/min is centrifuged 10min, collects serum.Serum SA buffer is taken to dilute 200 times.Serum 1mL after dilution is set into test tube
It is interior, 10% (v/v) SRBC of 0.5mL is sequentially added, complement 1mL (is diluted with SA liquid by 1:8).Separately set the control tube of not increase serum
(with the replacement of SA buffer).It sets after keeping the temperature 20min in 37 DEG C of waters bath with thermostatic control, ice bath terminates reaction.2000r/min is centrifuged 10min.
Supernatant 1mL is taken, Dou Shi reagent 3mL is added, while 10% (v/v) SRBC of 0.25mL being taken to add Dou Shi reagent to 4mL, it is sufficiently mixed
It is even, after placing 10min, blank is made with control tube at 540nm, measures each pipe OD value respectively.
The amount of hemolysin is with half hemolytic value (HC50) indicate, it is calculated according to the following formula:
The HC of test sample group50It is significantly higher than the HC of control group50, can determine that this experimental result positive.
4.3 monocytes/macrophages functions
1, mouse carbonic clearance is tested
Diluted india ink is injected from mouse tail vein, is calculated by every 10g weight 0.1mL.It injects to prepared Chinese ink, counts immediately
When.2,10min after injection prepared Chinese ink, take 20 μ L of blood from angular vein clump respectively, exist side by side and be added into the 1%Na of 2mL2CO3Solution
In, survey OD600nmSpleen blots organ surface blood stains with filter paper, weighing.
The ability of mouse carbonic clearance is indicated with phagocytic index.
K=(lgOD2min-1gOD10min)/(10min-2min)
The phagocytic index of test sample group is significantly higher than the phagocytic index of control group, can determine that this experimental result positive.
2, Turnover of Mouse Peritoneal Macrophages phagocytosis chicken red blood cell experiment (drop piece method)
2% (v/v) hematocrit SRBC0.2mL is injected to every mouse peritoneal and activates peritoneal macrophage, puts to death mouse after 5d,
Intraperitoneal injection plus calf serum Hank ' s liquid 4mL/ mouse, gently rub abdomen 20 times, and 1% chicken for drawing abdominal cavity washing lotion and equivalent is red
Cell mixes.1mL mixed liquor is drawn, piece is dripped, 37 DEG C of incubation 20min are rinsed, and fixed, Giemsa liquid dyeing, microscopy, counting gulps down
Biting rate and phagocytic index, (phagocytic rate is that percentage shared by the macrophage of chicken red blood cell is swallowed in every 100 macrophages;It gulps down
Bite the number that index is average each macrophage phagocytosis chicken red blood cell).
4.4NK cytoactive detection
1, lactic dehydrogenase (LDH) measuring method
It is sterile to take spleen, individual cells suspension is made as effector cell.Take target cell and each 100 μ L of effector cell (effect target
Than 50:1), it is added in U-shaped 96 well culture plate;Target cell Spontaneous release hole adds target cell and each 100 μ L of culture solution, and target cell is most
Big relief hole adds target cell and each 100 μ L of 2.5%Triton;Above-mentioned items are all provided with three multiple holes, in 37 DEG C, 5%CO2Incubator
Then 96 well culture plates are centrifuged 5min with 1500r/min by middle culture 4h, the culture of 100 μ L horizontalization bottom of supernatant, 96 hole is drawn in every hole
In plate, while 100 μ L of LDH matrix liquid is added, reacts 3min, the 30 μ L of HCl of 1mol/L is added in every hole, at microplate reader 490nm
It measures OD value (OD).
The NK cell activity of test sample group is significantly higher than the NK cell activity of control group, that is, can determine that this experimental result
It is positive.
Experimental result:
The experimental result of embodiment 19 is as shown in table 8.1 and 8.2.
Influence of 8.1 sample of table to mouse cell and humoral immune function
Note: control group is compared, P < 0.05 *, has significant difference;P < 0.01 * has extremely significant sex differernce.
By table 8.1 as it can be seen that low, middle dose group lymphopoiesis ability and auricle swelling degree weight gain are higher than control group,
With significant difference (P < 0.05), lymphopoiesis ability and the auricle swelling degree weight gain of high dose group are higher than control group,
With extremely significant sex differernce (P < 0.01);The half hemolytic value of middle and high dosage group be higher than control group, have significant difference (P <
0.05)。
8.2 sample of table is to mouse monokaryon-macrophage and NK cytoactive detection result
Note: control group is compared, P < 0.05 *, has significant difference;P < 0.01 * has extremely significant sex differernce.
By table 8.2 as it can be seen that the NK cell activity of middle dose group is higher than control group, have significant difference (P < 0.05), it is high
The NK cell activity of dosage group is higher than control group, has extremely significant sex differernce (P < 0.01).
The Evaluation of Immunity experimental result of comparative example 7 is as shown in table 9.1 and table 9.2.
Influence of 9.1 sample of table to mouse cell and humoral immune function
Note: control group is compared, P < 0.05 *, has significant difference.
By table 9.1 as it can be seen that lymphopoiesis ability and the auricle swelling degree weight gain of middle and high dosage group are higher than control group,
With significant difference (P < 0.05).
9.2 sample of table is to mouse monokaryon-macrophage and NK cytoactive detection result
Note: P < 0.05 * indicates there is significant difference compared with the control group.
By table 9.2 as it can be seen that the NK cell activity of high dose group is higher than control group, have significant difference (P < 0.05).
Intact animal experiment is all made of in the application.In cellular immune function, humoral immune function, monocytes/macrophages
In the four aspect measurements of function and NK cell activity, any two aspect test results are the positive, it is possible to determine that given the test agent tool
There is strengthen immunity effect.Wherein the result of two experiments is the positive or any experiment in cellular immune function assay project
Two dosage group results be the positive, determine that cellular immune function test result is positive.Two in humoral immune function measurement item
The result of a experiment is two dosage group results of the positive or any experiment for the positive, determines humoral immune function test knot
Fruit is positive.The result of two experiments is two agent of the positive or any experiment in mononuclear-macrophage function assay project
Amount group result is the positive, determines that monokaryon-macrophage function test result is positive.NK cytoactive detection experiment one with
Upper Dose Results are positive, determine that NK cell activity result is positive.
Therefore, the present embodiment 19 has the effect of strengthen immunity, meanwhile, by comparative example 7 it can be found that inulin and fish
Collagen peptide synergistic effect, can significantly improve the spot number hemolysis value and NK cell activity of composition, to play better
Immunization.
Claims (10)
1. one kind helps pregnant composition, which is characterized in that the raw material including following parts by weight: 2-6 parts of semen sojae atricolor, black-bone chicken albumen powder 5-13
Part, 1-7 parts of pollen pini, 1-6 parts of L-carnitine, 4-9 parts of ginger and 2-8 parts of Radix Angelicae Sinensis.
2. according to claim 1 help pregnant composition, which is characterized in that described helps pregnant composition, including following weight
The raw material of part: 3-6 parts of semen sojae atricolor, 6-13 parts of black-bone chicken albumen powder, 2-7 parts of pollen pini, 2-6 parts of L-carnitine, 5-9 parts of ginger and Radix Angelicae Sinensis
4-8 parts.
3. according to claim 2 help pregnant composition, which is characterized in that further include the raw material of following parts by weight: zinc-rich is rich
5-10 parts of selenium dried whole-egg, 1-5 parts of fructus lycii, 2-7 parts of Chinese yam, 2-6 parts of lotus seeds, 3-8 parts of longan, 1-5 parts of cortex cinnamomi and 5-15 parts of jujube.
4. according to claim 3 help pregnant composition, which is characterized in that further include the raw material of following parts by weight: fruit vegetable powder
8-15 parts, 1-8 parts of motherwort, 1-5 parts of trehalose, 1-6 parts of pueraria lobata, 2-8 parts of folium artemisiae argyi and 0.001-0.005 parts of vitamin.
5. according to claim 4 help pregnant composition, which is characterized in that the vitamin be vitamin C, vitamin E,
Folic acid, vitamin B1, vitamin B2, vitamin B6, vitamin B12, one of niacin and pantothenic acid or a variety of.
6. according to claim 5 help pregnant composition, which is characterized in that further include the raw material of following parts by weight: honey 5-
10 parts, 3-8 parts of inulin, 2-7 parts of Isin glue collagen peptide, 1-5 parts of maca and 0.0001-0.0005 parts of microelement.
7. according to claim 6 help pregnant composition, which is characterized in that the microelement is molysite, mantoquita and molybdenum
One of salt is a variety of.
8. a kind of prepare the described in any item methods for helping pregnant composition of claim 1-7, which is characterized in that the preparation side
Method, comprising the following steps:
(1) black-bone chicken albumen powder, pollen pini, Zinc-enriched selenium-enriched dried whole-egg, fruit vegetable powder, honey, inulin, Isin glue collagen peptide, dimension will be removed
All raw materials except raw element and microelement are freeze-dried, are crushed into powder, obtain after the dosage mixing of composition of raw materials
Mixture A;
(2) obtained mixture A is extracted with ethanol solution, is filtered after merging filtrate, is concentrated under reduced pressure to give medicinal extract B, it is described
Mixture A and ethyl alcohol mass ratio be 1:(4-7);
(3) obtained medicinal extract B is obtained into mixture C after drying, crushing, sieving;
(4) mixture C that step (3) obtains is sufficiently mixed with remaining raw material is formulated, obtains described helping pregnant composition.
9. preparation method according to claim 8, which is characterized in that the condition of extraction described in step (2) are as follows:
It is extracted 3 times at 60-70 DEG C, 3 hours each extraction times, the ethanol solution is the ethanol water that volume fraction is 60-80%
Solution.
10. the described in any item compositions of claim 1-7 are preparing the application in health care product and/or functional food.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811621491.6A CN109620951A (en) | 2018-12-28 | 2018-12-28 | One kind helping pregnant composition and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811621491.6A CN109620951A (en) | 2018-12-28 | 2018-12-28 | One kind helping pregnant composition and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109620951A true CN109620951A (en) | 2019-04-16 |
Family
ID=66078786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811621491.6A Pending CN109620951A (en) | 2018-12-28 | 2018-12-28 | One kind helping pregnant composition and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109620951A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112056408A (en) * | 2020-09-03 | 2020-12-11 | 山东哈维药业有限公司 | Compound protein nutrient for female pregnancy preparation and preparation method thereof |
CN113730558A (en) * | 2021-09-09 | 2021-12-03 | 广东圆康再生医学科技开发有限公司 | Ovarian oocyte repair composition and preparation method thereof |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101502605A (en) * | 2009-03-06 | 2009-08-12 | 天科仁祥技术(北京)有限责任公司 | Medicament composition for treating infertility and preparation method thereof |
CN105876439A (en) * | 2014-12-30 | 2016-08-24 | 江西建昌帮中药饮片有限公司 | Immunity-enhancing and fatigue-resisting traditional Chinese medicine health-care product and preparation method thereof |
CN105999233A (en) * | 2016-05-04 | 2016-10-12 | 上海昭远生物工程有限公司 | Medicine for treating female infertility and preparation method thereof |
CN106924697A (en) * | 2017-03-28 | 2017-07-07 | 北海市宝珠林海洋科技有限公司 | A kind of pearl health-care Chinese medicine package |
CN106942748A (en) * | 2017-03-29 | 2017-07-14 | 上海奥医生物医药科技有限公司 | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof |
US20170246230A1 (en) * | 2014-05-13 | 2017-08-31 | Sichuan Sainthood Biotech Co., Ltd. | Pharmaceutical composition for treating infertility, and preparation method and use thereof |
CN107233491A (en) * | 2017-06-12 | 2017-10-10 | 拉萨净土睿健生物产业发展有限公司 | It is a kind of to improve the antifatigue maca composition of energy |
CN107361360A (en) * | 2017-07-24 | 2017-11-21 | 冯纪敏 | A kind of composition and its application |
CN107373672A (en) * | 2017-08-23 | 2017-11-24 | 上海奥医生物医药科技有限公司 | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof |
CN107772433A (en) * | 2016-08-31 | 2018-03-09 | 江苏康缘药业股份有限公司 | One kind, which has, alleviates physical fatigue, strengthen immunity composition and preparation method thereof |
CN107927790A (en) * | 2017-12-08 | 2018-04-20 | 冯纪敏 | A kind of composition and its application |
CN109007857A (en) * | 2018-08-29 | 2018-12-18 | 苏州佩普肽康生物科技有限公司 | Improve the food formula of special diet and preparation method thereof of mankind spermatozoon quality |
-
2018
- 2018-12-28 CN CN201811621491.6A patent/CN109620951A/en active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101502605A (en) * | 2009-03-06 | 2009-08-12 | 天科仁祥技术(北京)有限责任公司 | Medicament composition for treating infertility and preparation method thereof |
US20170246230A1 (en) * | 2014-05-13 | 2017-08-31 | Sichuan Sainthood Biotech Co., Ltd. | Pharmaceutical composition for treating infertility, and preparation method and use thereof |
CN105876439A (en) * | 2014-12-30 | 2016-08-24 | 江西建昌帮中药饮片有限公司 | Immunity-enhancing and fatigue-resisting traditional Chinese medicine health-care product and preparation method thereof |
CN105999233A (en) * | 2016-05-04 | 2016-10-12 | 上海昭远生物工程有限公司 | Medicine for treating female infertility and preparation method thereof |
CN107772433A (en) * | 2016-08-31 | 2018-03-09 | 江苏康缘药业股份有限公司 | One kind, which has, alleviates physical fatigue, strengthen immunity composition and preparation method thereof |
CN106924697A (en) * | 2017-03-28 | 2017-07-07 | 北海市宝珠林海洋科技有限公司 | A kind of pearl health-care Chinese medicine package |
CN106942748A (en) * | 2017-03-29 | 2017-07-14 | 上海奥医生物医药科技有限公司 | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof |
CN107233491A (en) * | 2017-06-12 | 2017-10-10 | 拉萨净土睿健生物产业发展有限公司 | It is a kind of to improve the antifatigue maca composition of energy |
CN107361360A (en) * | 2017-07-24 | 2017-11-21 | 冯纪敏 | A kind of composition and its application |
CN107373672A (en) * | 2017-08-23 | 2017-11-24 | 上海奥医生物医药科技有限公司 | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof |
CN107927790A (en) * | 2017-12-08 | 2018-04-20 | 冯纪敏 | A kind of composition and its application |
CN109007857A (en) * | 2018-08-29 | 2018-12-18 | 苏州佩普肽康生物科技有限公司 | Improve the food formula of special diet and preparation method thereof of mankind spermatozoon quality |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112056408A (en) * | 2020-09-03 | 2020-12-11 | 山东哈维药业有限公司 | Compound protein nutrient for female pregnancy preparation and preparation method thereof |
CN113730558A (en) * | 2021-09-09 | 2021-12-03 | 广东圆康再生医学科技开发有限公司 | Ovarian oocyte repair composition and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102172269B (en) | Hidegelatin fabricated food with beautification function | |
US10406195B2 (en) | Solid drink for regulating phlegm-dampness constitution and processing method thereof | |
CN101708048B (en) | Health-care food and preparation method thereof | |
CN102526477B (en) | Medicine composition for enhancing immunities as well as preparation method and application thereof | |
CN109645497A (en) | A kind of composition and preparation method thereof improving male fertility | |
CN104706704A (en) | Maca compositions, and compound preparation and application thereof | |
CN109620951A (en) | One kind helping pregnant composition and preparation method thereof | |
CN104127577A (en) | Chinese medicine capsule for relieving physical fatigue and preparation method of Chinese medicine capsule | |
CN107048386A (en) | A kind of sexual function adjusts health food | |
CN105497261A (en) | Matrix of patch for external use and patch and sleeping-aid patch made from matrix | |
CN104489172A (en) | Acanthopanax health tea for improving immunity and preparation method thereof | |
CN109453355A (en) | It is a kind of to prevent the high composition of pregnancy period three, drinks and preparation method thereof | |
CN108066384A (en) | A kind of Chinese medicine preparation with strengthen immunity and preparation method thereof | |
CN104645297B (en) | A kind of temperature palace helps pregnant Chinese medicine composition and its formulation preparation method | |
CN108186966A (en) | A kind of composition for preventing or improving senile dementia and its application | |
CN106666733A (en) | Nourishing paste with functions of producing blood, tonifying kidney, blacking hair and strengthening physique | |
CN102715503A (en) | Immunity-regulating TCM (traditional Chinese medicine) health food and preparation method thereof | |
CN107233491A (en) | It is a kind of to improve the antifatigue maca composition of energy | |
CN102357151A (en) | Chinese medicinal composition for delaying senility and preparation process thereof | |
CN112494569A (en) | Traditional Chinese medicine composition for improving immunity and preparation method and application thereof | |
CN107019745A (en) | A kind of composition with strengthen immunity function and preparation method thereof | |
CN112336843A (en) | Zhuang medicine composition with functions of chest strengthening and breast enlarging, pills and preparation method and application of pills | |
CN103251816A (en) | Preparation for enhancing immunity and preparation method thereof | |
CN103330898A (en) | Traditional Chinese medicine composition for curing impotence and prospermia, as well as preparation method and application of traditional Chinese medicine composition | |
CN108524850A (en) | A kind of liquor preparation for enhancing immune prevention cardiovascular and cerebrovascular disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190416 |
|
RJ01 | Rejection of invention patent application after publication |